学术探索
学术期刊
新闻热点
数据分析
智能评审

Peroxisome proliferator-activated receptors - from active regulators of macrophage biology to pharmacological targets in the treatment of cardiovascular disease

被引：39
作者：
Bouhlel, M. A. [1 ,2 ]
Staels, B. [1 ,2 ]
Chinetti-Gbaguidi, G. [1 ,2 ]
机构：
[1] Inst Pasteur, INSERM, Dept Atherosclerose, U545, Lille, France
[2] Univ Lille 2, Fac Med, Fac Sci Pharmaceut & Biol, Lille, France
来源：
JOURNAL OF INTERNAL MEDICINE | 2008年 / 263卷 / 01期
关键词：
cardiovascular disease; gene regulation; macrophages; peroxisome proliferator-activated receptor;
D O I：
10.1111/j.1365-2796.2007.01892.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Altered macrophage functions contribute to the pathogenesis of many infectious, immunological and inflammatory disease processes. Pharmacological modulation of macrophage activities therefore represents an important strategy for the prevention and treatment of inflammation-related diseases, such as atherosclerosis. This review focuses on recent advances on the role of the peroxisome proliferator-activated receptor transcription factor family in the modulation of lipid homeostasis and the inflammatory response in macrophages and the potential participation of these actions in the modulation of metabolic and cardiovascular disease.
引用
收藏
页码：28 / 42
页数：15
相关论文
共 128 条
[11]   The mouse CCR2 gene is regulated by two promoters that are responsive to plasma cholesterol and peroxisome proliferator-activated receptor γ ligands [J].
Chen, YM ;
Green, SR ;
Ho, J ;
Li, A ;
Almazan, F ;
Quehenberger, O .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 332 (01) :188-193
[12]   CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors [J].
Chinetti, G ;
Gbaguidi, FG ;
Griglio, S ;
Mallat, Z ;
Antonucci, M ;
Poulain, P ;
Chapman, J ;
Fruchart, JC ;
Tedgui, A ;
Najib-Fruchart, J ;
Staels, B .
CIRCULATION, 2000, 101 (20) :2411-2417
[13]   Peroxisome proliferator-activated receptor α reduces cholesterol esterification in macrophages [J].
Chinetti, G ;
Lestavel, S ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
CIRCULATION RESEARCH, 2003, 92 (02) :212-217
[14]   PPAR-α and PPAR-γ activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway [J].
Chinetti, G ;
Lestavel, S ;
Bocher, V ;
Remaley, AT ;
Neve, B ;
Torra, IP ;
Teissier, E ;
Minnich, A ;
Jaye, M ;
Duverger, N ;
Brewer, HB ;
Fruchart, JC ;
Clavey, V ;
Staels, B .
NATURE MEDICINE, 2001, 7 (01) :53-58
[15]   Peroxisome proliferator-activated receptor α controls cellular cholesterol trafficking in macrophages [J].
Chinetti-Gbaguidi, G ;
Rigamonti, E ;
Helin, L ;
Mutka, AL ;
Lepore, M ;
Fruchart, JC ;
Clavey, V ;
Ikonen, E ;
Lestavel, S ;
Staels, B .
JOURNAL OF LIPID RESEARCH, 2005, 46 (12) :2717-2725
[16]   IL-6 switches the differentiation of monocytes from dendritic cells to macrophages [J].
Chomarat, P ;
Banchereau, J ;
Davoust, J ;
Palucka, AK .
NATURE IMMUNOLOGY, 2000, 1 (06) :510-514
[17]   Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial [J].
Colhoun, HM ;
Betteridge, DJ ;
Durrington, PN ;
Hitman, GA ;
Neil, HAW ;
Livingstone, SJ ;
Thomason, MJ ;
Mackness, MI ;
Charlton-Menys, V ;
Fuller, JH .
LANCET, 2004, 364 (9435) :685-696
[18]   Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation [J].
da Cunha, V ;
Tham, DM ;
Martin-McNulty, B ;
Deng, G ;
Ho, JJ ;
Wilson, DW ;
Rutledge, JC ;
Vergona, R ;
Sullivan, ME ;
Wang, YX .
ATHEROSCLEROSIS, 2005, 178 (01) :9-17
[19]   Macrophage scavenger receptors and foam cell formation [J].
de Villiers, WJS ;
Smart, EJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 1999, 66 (05) :740-746
[20]   Peroxisome proliferator-activated receptors in inflammation control [J].
Delerive, P ;
Fruchart, JC ;
Staels, B .
JOURNAL OF ENDOCRINOLOGY, 2001, 169 (03) :453-459
12345678910